Browse by Supervisor

Austen, Belinda (2007). A study of the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukaemia. University of Birmingham. Ph.D.

Skowrońska, Anna Maria (2013). ATM mutant cellular phenotype in B-cell chronic lymphocytic leukaemia: clinical consequences and therapeutic implications. University of Birmingham. Ph.D.

Wilson, Shaun Robert (2014). An investigation into the role of receptor tyrosine kinases in childhood Acute Lymphoblastic Leukaemia. University of Birmingham. Ph.D.

Francis, Tegan Adeline (2015). An investigation of tumour susceptibility in a modified ATM-/- mouse with no thymoma risk. University of Birmingham. Ph.D.

Vanderstichelen, Gaelle Michele (2022). Application of nuclear magnetic resonance spectroscopy for the detection of metabolic changes in blood cells with defective DNA repair. University of Birmingham. Ph.D.

Lawrence, Kirsty Josephine (2016). Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development. University of Birmingham. Ph.D.

Alatawi, Sael Musallam ORCID: 0000-0001-5773-5567 (2022). Epigenetic characterisation of chronic lymphocytic leukaemia with frequently altered DNA damage response genes. University of Birmingham. Ph.D.

Cartwright, David Michael (2013). Investigating the synthetic lethal effects of poly (ADP-ribose) polymerase and histone deacetylase inhibition in progressive B-Cell chronic lymphocytic leukaemia deficient in the ATM pathway and Optimisation of multiple marker imaging of immunological tissue using confocal laser scanning fluorescence microscopy. University of Birmingham. M.Res.

Da Costa, David (2014). Molecular characterisation of paediatric ALL and new therapeutic strategies. University of Birmingham. Ph.D.

Kwok, Marwan Cheng Kuang (2018). Novel insights into the clinical heterogeneity and treatment of chronic lymphocytic leukaemia. University of Birmingham. Ph.D.

Longman, Joanna (2013). Project 1: Novel bromodomain and extra-terminal (BET) protein inhibitor JQ1 sensitises dexamethasone-resistant ALL cells to dexamethasone-induced cell killing and Does microRNA deregulation contribute to PTTGl-Binding Factor (PBF) overexpression in thyroid carcinoma? Project 2: Does microRNA deregulation contribute to PTTG1-Binding Factor (PBF) overexpression in thyroid carcinoma? University of Birmingham. M.Res.

Bowry, Akhil (2020). Role of BET family of transcription regulators in DNA replication stress. University of Birmingham. Ph.D.